why choose us

First received: December 15, 2022

Clinical Trial: Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cytomegalovirus

Study Type: INTERVENTIONAL


Official Title: Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Brief Summary: The investigators want to learn if CMV- and ADV-specific T-cells (cells that fight infections) isolated (selected) from a donor using an automated medical device can be a safe treatment for treating patients with CMV, and ADV after transplant.This study will test the effects and safety of giving VSTs produced here at St. Jude in treating the participant's infection.Primary objectiveTo determine the efficacy of VSTs to achieve a ?1 log10 reduction in CMV and/or ADV viral load in the peripheral blood 4…

Read more